tirzepatide osa trial #Mounjaro/#zepbound (tirzepatide) for obesity complicated by sleep apnea trials presented at #ADA2024 and published in @nejm1️⃣ Participants who were not receiving treatment with positive airway FDA approves tirzepatide to treat

For standard use, apply it after cleansing and conditioning as the final leave-in treatment

If you have low vitamin B12, you will most likely struggle in the health department

Li et al., 2014) and studies have demonstrated that MOTS-c and metformin may share similar metabolic regulatory mechanisms ( Our previous studies demonstrated that aerobic exercise of skeletal muscle activates AMPK and its downstream proliferation-activated receptor coactivator PGC-1, thereby increasing MOTS-c expression

A peptide is simply a short chain of amino acids

Recalls & Warnings January 09, 2014 Four Companies Settle FTC Charges of Deceptive Weight Loss Claims On January 7, 2014, the Federal Trade Commission (FTC) announced that marketers for four weight loss products have agreed to settlements over charges of deceptive weight loss claims

Women using oral hormonal contraceptives should use a non-oral method or add a backup method for 4 weeks after starting tirzepatide and after each dose increase